|Min SIP Amount||₹500|
|NAV||₹10.14 (30 Oct 2020)|
|Fund Started||29 Dec 2019|
|Fund Size||₹230 Cr|
|Reliance Industries Ltd.||Energy||Equity||4.2%|
|HDFC Bank Ltd.||Financial||Equity||3.5%|
|ICICI Bank Ltd.||Financial||Equity||3.5%|
|Ipca Laboratories Ltd.||Healthcare||Equity||2.8%|
|Tata Consultancy Services Ltd.||Technology||Equity||2.7%|
|Hindustan Unilever Ltd.||FMCG||Equity||2.7%|
|Bayer CropScience Ltd.||Healthcare||Equity||2.6%|
|Strides Pharma Science Ltd.||Healthcare||Equity||2.5%|
Mahindra Manulife Top 250 Nivesh Yojana Direct Growth is a Equity Mutual Fund Scheme launched by Mahindra Mutual Fund. This scheme was made available to investors on 29 Dec 2019. V Balasubramanian is the Current Fund Manager of Mahindra Manulife Top 250 Nivesh Yojana Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹230 Cr and the Latest NAV as of 30 Oct 2020 is ₹10.14.
The Mahindra Manulife Top 250 Nivesh Yojana Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 1000. Exit load of 1%, if redeemed within 1 year.
The Scheme seeks long term capital growth through investments in equity and equity related securities of both large cap and mid cap stocks.